Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks how well psoriasis drugs work in daily life

NCT ID NCT04818385

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times

Summary

This study looked at 240 adults in Taiwan with moderate to severe plaque psoriasis, a chronic skin condition causing red, scaly patches. Researchers compared the drug risankizumab to other biologic treatments to see how long it keeps skin clear. Participants were followed for about 2 years, and the study aimed to understand real-world treatment durability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • China Medical University Hospital /ID# 229961

    Taichung, 40447, Taiwan

  • Hualien Tzu Chi Hospital /ID# 238431

    Hualien City, 97002, Taiwan

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 230016

    Kaohsiung City, 807, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 253775

    Taoyuan City, 333, Taiwan

  • National Cheng Kung University Hospital /ID# 253776

    Tainan, 704, Taiwan

  • National Taiwan University Hospital - Hsinchu branch /ID# 238432

    Hsinchu, 30059, Taiwan

  • National Taiwan University Hospital /ID# 230017

    Taipei City, Taipei, 100, Taiwan

  • Taipei Medical University Hospital /ID# 230018

    Taipei, 11031, Taiwan

Conditions

Explore the condition pages connected to this study.